Clinical Trials Browser

Phase 3 × Unknown × Sirolimus × Clear all

NCT00554125 2007-11-06

Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

Phase 3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular